{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:18:51Z","timestamp":1788963531188,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Locoregional recurrence (LRR) poses a persistent clinical challenge in breast cancer, with emerging evidence implicating the tumor-associated adipose tissue in modulating recurrence risk. This study investigates shared transcriptional programs between adipose tissue and breast tumors and examines their association with disease-free survival (DFS), particularly in the context of reconstructive surgery where adipose tissue from different body compartments are commonly used. We analyzed bulk gene expression data from 5,691 breast tumors and 978 human adipose tissue samples from different body compartments using consensus-independent component analysis (c-ICA) to identify transcriptional components (TCs). Gene set enrichment analysis (GSEA) and copy number alteration profiling were used for biological annotation. Associations between TCs and DFS were evaluated through univariate Cox regression. Key findings were validated using spatial transcriptomic and single-cell RNA sequencing datasets. Among the 411 TCs identified, 332 showed biological enrichment, and 35 were significantly associated with DFS. Four DFS-associated TCs (TC257, TC350, TC371, TC400) were enriched for adipogenesis-related genes and exhibited heightened activity in high-grade, triple-negative tumors and in patients with elevated BMI. Notably, TC350 was highly active in adipose tissue from common reconstructive donor sites (abdomen, omentum, subcutis) but not in native breast adipose tissue. Spatial transcriptomic and single-cell analyses confirmed the increased activity of these adipogenesis-related TCs in tumor regions and adipose cells. TC350 included\u00a0\n                    <jats:italic>FABP4<\/jats:italic>\n                    , a gene previously linked to poor prognosis in breast cancer and considered as a potential new therapeutic target. Adipose tissue-derived transcriptional programs influence breast cancer prognosis and this seems to differ by tissue origin. These findings generate a hypothesis that donor site selection for adipose tissue in reconstructive surgery may impact LRR risk through adipogenesis-associated mechanisms. Further research is warranted to elucidate the biological and clinical implications of adipose\u2013tumor transcriptional interactions.\n                  <\/jats:p>","DOI":"10.1007\/s10142-026-02012-w","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:56:03Z","timestamp":1788918963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the transcriptional crosstalk between adipose tissue and locoregional recurrence in breast cancer using independent component analysis"],"prefix":"10.1007","volume":"26","author":[{"given":"Marlous","family":"Arjaans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"van der Vegt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renske","family":"Linstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf S. N.","family":"Fehrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkajyoti","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"issue":"1","key":"2012_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41467-020-14605-5","volume":"11","author":"A Bhattacharya","year":"2020","unstructured":"Bhattacharya A, Bense RD, Urz\u00faa-Traslavi\u00f1a CG, de Vries EGE, van Vugt MATM, Fehrmann RSN (2020) Transcriptional effects of copy number alterations in a large set of human cancers. Nat Commun 11(1):715","journal-title":"Nat Commun"},{"key":"2012_CR2","doi-asserted-by":"publisher","first-page":"PR101369","DOI":"10.7554\/eLife.101369","volume":"13","author":"A Bhattacharya","year":"2025","unstructured":"Bhattacharya A, Stutvoet TS, Perla M, Loipfinger S, Jalving M, Reyner AKL et al (2025) Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancer. eLife 13:PR101369","journal-title":"eLife"},{"issue":"6","key":"2012_CR3","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/oby.22458","volume":"27","author":"PT Bradshaw","year":"2019","unstructured":"Bradshaw PT, Cespedes Feliciano EM, Prado CM, Alexeeff S, Albers KB, Chen WY et al (2019) Adipose tissue distribution and survival among women with nonmetastatic breast cancer. Obesity (Silver Spring) 27(6):997\u20131004","journal-title":"Obesity (Silver Spring)"},{"issue":"319","key":"2012_CR4","doi-asserted-by":"publisher","first-page":"319ra205","DOI":"10.1126\/scitranslmed.aac6336","volume":"7","author":"MF Burak","year":"2015","unstructured":"Burak MF, Inouye KE, White A, Lee A, Tuncman G, Calay ES et al (2015) Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes. Sci Transl Med 7(319):319ra205","journal-title":"Sci Transl Med"},{"issue":"5","key":"2012_CR5","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.cmet.2013.04.012","volume":"17","author":"H Cao","year":"2013","unstructured":"Cao H, Sekiya M, Ertunc ME, Burak MF, Mayers JR, White A et al (2013) Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production. Cell Metab 17(5):768\u2013778","journal-title":"Cell Metab"},{"issue":"6","key":"2012_CR6","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1089\/cmb.2004.11.1090","volume":"11","author":"P Chiappetta","year":"2004","unstructured":"Chiappetta P, Roubaud MC, Torr\u00e9sani B (2004) Blind source separation and the analysis of microarray data. J Comput Biol 11(6):1090\u20131109","journal-title":"J Comput Biol"},{"issue":"2","key":"2012_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1053\/ctrv.2000.0204","volume":"27","author":"M Clemons","year":"2001","unstructured":"Clemons M, Danson S, Hamilton T, Goss P (2001) Locoregionally recurrent breast cancer: incidence, risk factors and survival. Cancer Treat Rev 27(2):67\u201382","journal-title":"Cancer Treat Rev"},{"key":"2012_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","volume":"1418","author":"E Clough","year":"2016","unstructured":"Clough E, Barrett T (2016) The gene expression omnibus database. Methods Mol Biol 1418:93\u2013110","journal-title":"Methods Mol Biol"},{"issue":"8","key":"2012_CR9","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","volume":"26","author":"AS Coates","year":"2015","unstructured":"Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M et al (2015) Tailoring therapies\u2013improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann Oncol 26(8):1533\u20131546","journal-title":"Ann Oncol"},{"issue":"7","key":"2012_CR10","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-10-3323","volume":"71","author":"B Dirat","year":"2011","unstructured":"Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B et al (2011) Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 71(7):2455\u20132465","journal-title":"Cancer Res"},{"issue":"1","key":"2012_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/scd.2008.0055","volume":"18","author":"J Douville","year":"2009","unstructured":"Douville J, Beaulieu R, Balicki D (2009) ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev 18(1):17\u201325","journal-title":"Stem Cells Dev"},{"issue":"1","key":"2012_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11033-025-11302-8","volume":"53","author":"NAA Ebrahim","year":"2025","unstructured":"Ebrahim NAA, Farghaly TA, Soliman SMA (2025a) Rewiring the transcriptome: diagnostic and therapeutic implications of alternative splicing in solid cancers. Mol Biol Rep 53(1):125","journal-title":"Mol Biol Rep"},{"key":"2012_CR13","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1186\/s12885-025-14402-7","volume":"25","author":"NAA Ebrahim","year":"2025","unstructured":"Ebrahim NAA, Hussein MA, Sobeih ME et al (2025b) From biomarker to targeted therapy: investigating trophoblast cell-surface antigen 2 expression in triple-negative breast cancer\u2013 insights from the national cancer institute. BMC Cancer. 25:1008","journal-title":"BMC Cancer."},{"key":"2012_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s40944-025-01060-7","author":"NAA Ebrahim","year":"2025","unstructured":"Ebrahim NAA, Amin NH, Hussein MA (2025c) Immunohistochemical profiling of EGFR in triple-negative breast cancer: diagnostic utility and prognostic impact. Indian J Gynecol Oncol. https:\/\/doi.org\/10.1007\/s40944-025-01060-7","journal-title":"Indian J Gynecol Oncol"},{"key":"2012_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12032-025-03217-y","volume":"43","author":"NAA Ebrahim","year":"2026","unstructured":"Ebrahim NAA, Farghaly TA, Soliman SMA (2026) Exosomal blueprint of lung-tropic metastasis: molecular signatures, microenvironmental conditioning, and translational implications in cancer. Med Oncol 43:93","journal-title":"Med Oncol"},{"issue":"2","key":"2012_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/ng.3173","volume":"47","author":"RS Fehrmann","year":"2015","unstructured":"Fehrmann RS, Karjalainen JM, Krajewska M, Westra HJ, Maloney D, Simeonov A et al (2015) Gene expression analysis identifies global gene dosage sensitivity in cancer. Nat Genet 47(2):115\u2013125","journal-title":"Nat Genet"},{"issue":"1 Suppl","key":"2012_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/cncr.2820741333","volume":"74","author":"LJ Feng","year":"1994","unstructured":"Feng LJ, Mauceri K, Berger BE (1994) Autogenous tissue breast reconstruction in the silicone-intolerant patient. Cancer 74(1 Suppl):440\u2013449","journal-title":"Cancer"},{"issue":"5","key":"2012_CR18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier C, Hee Hur M, Charafe-Jauffret E, Monville F, Dutcher J, Brown M et al (2007) ALDGH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1(5):555\u2013567","journal-title":"Cell Stem Cell"},{"issue":"Pt B","key":"2012_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.mce.2017.02.002","volume":"462","author":"S Guaita-Esteruelas","year":"2018","unstructured":"Guaita-Esteruelas S, Gum\u00e0 J, Masana L, Borr\u00e0s J (2018) The peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5. Mol Cell Endocrinol 462(Pt B):107\u2013118","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"2012_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1200\/JOP.777003","volume":"6","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Wolff AC, Mangu PB, Temin S (2010) American society of clinical oncology\/college of American pathologist\u2019s guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract 6(4):195\u2013197","journal-title":"J Oncol Pract"},{"key":"2012_CR21","doi-asserted-by":"publisher","first-page":"5156","DOI":"10.1016\/j.clnu.2021.08.003","volume":"40","author":"J Han","year":"2021","unstructured":"Han J, Tang M, Lu C, Shen L, She J, Wu G (2021) Subcutaneous, but not visceral, adipose tissue as a marker for prognosis in gastric cancer patients with cachexia. Clin Nutr 40:5156\u20135161","journal-title":"Clin Nutr"},{"issue":"3","key":"2012_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21(3):309\u2013322","journal-title":"Cancer Cell"},{"issue":"5","key":"2012_CR23","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674","journal-title":"Cell"},{"issue":"2","key":"2012_CR24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10549-009-0577-9","volume":"119","author":"K Hancke","year":"2010","unstructured":"Hancke K, Grubeck D, Hauser N, Kreienberg R, Weiss JM (2010) Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer pa- tients. Breast Cancer Res Treat 119(2):367\u2013377","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"2012_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10549-009-0577-9","volume":"119","author":"K Hancke","year":"2010","unstructured":"Hancke K, Grubeck D, Hauser N, Kreienberg R, Weiss JM (2010) Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients. Breast Cancer Res Treat 119(2):367\u2013377","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"2012_CR26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cmet.2018.07.006","volume":"28","author":"J Hao","year":"2018","unstructured":"Hao J, Zhang Y, Yan X, Yan F, Sun Y, Zeng J et al (2018) Circulating adipose fatty acid binding protein is a new link underlying obesity-associated breast\/mammary tumor development. Cell Metab 28(5):689-705.e5","journal-title":"Cell Metab"},{"issue":"1","key":"2012_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13058-024-01873-y","volume":"26","author":"J Hao","year":"2024","unstructured":"Hao J, Jin R, Yi Y, Jiang X, Yu J, Xu Z et al (2024) Development of a humanized anti-FABP4 monoclonal antibody for potential treatment of breast cancer. Breast Cancer Res 26(1):119","journal-title":"Breast Cancer Res"},{"key":"2012_CR28","doi-asserted-by":"publisher","first-page":"752","DOI":"10.4093\/dmj.2019.0174","volume":"43","author":"I Hwang","year":"2019","unstructured":"Hwang I, Kim JB (2019) Two faces of White Adipose tissue with heterogeneous adipogenic progenitors. Diabetes Metab J 43:752\u2013762","journal-title":"Diabetes Metab J"},{"key":"2012_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1467-789X.2009.00623.x","volume":"11","author":"MM Ibrahim","year":"2010","unstructured":"Ibrahim MM (2010) Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 11:11\u201318","journal-title":"Obes Rev"},{"issue":"1","key":"2012_CR30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.gie.2018.02.040","volume":"88","author":"JP Im","year":"2018","unstructured":"Im JP, Kim D, Chung SJ, Jin EH, Han YM, Park MJ et al (2018) Visceral obesity as a risk factor for colorectal adenoma occurrence in surveillance colonoscopy. Gastrointest Endosc 88(1):119-127.e4","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"2012_CR31","doi-asserted-by":"publisher","first-page":"e0119473","DOI":"10.1371\/journal.pone.0119473","volume":"10","author":"S Kim","year":"2015","unstructured":"Kim S, Lee Y, Koo JS (2015) Differential expression of lipid metabolism-related proteins in different breast cancer subtypes. PLoS ONE 10(3):e0119473","journal-title":"PLoS ONE"},{"issue":"1","key":"2012_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s43856-024-00504-z","volume":"4","author":"DG Knapen","year":"2024","unstructured":"Knapen DG, Hone Lopez S, de Groot DJA, de Haan JJ, de Vries EGE, Dienstmann R et al (2024) Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer. Commun Med (Lond) 4(1):79","journal-title":"Commun Med (Lond)"},{"issue":"1","key":"2012_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1245\/s10434-012-2565-2","volume":"20","author":"TK Krastev","year":"2013","unstructured":"Krastev TK, Jonasse Y, Kon M (2013) Oncological safety of autologous lipoaspirate grafting in breast cancer patients: a systematic review. Ann Surg Oncol 20(1):111\u2013119","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"2012_CR34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.breast.2011.01.003","volume":"20","author":"V Lohsiriwat","year":"2011","unstructured":"Lohsiriwat V, Curigliano G, Rietjens M, Goldhirsch A, Petit JY (2011) Autologous fat transplantation in patients with breast cancer: \u201csilencing\u201d or \u201cfueling\u201d cancer recurrence? Breast 20(4):351\u2013357","journal-title":"Breast"},{"issue":"W1","key":"2012_CR35","doi-asserted-by":"publisher","first-page":"W566","DOI":"10.1093\/nar\/gkv468","volume":"43","author":"T Metsalu","year":"2015","unstructured":"Metsalu T, Vilo J (2015) ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap. Nucleic Acids Res 43(W1):W566\u2013W570","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2012_CR36","doi-asserted-by":"publisher","first-page":"12541","DOI":"10.1038\/s41598-021-91897-7","volume":"11","author":"M Oshi","year":"2021","unstructured":"Oshi M, Tokumaru Y, Angarita FA, Lee L, Yan L, Matsuyama R et al (2021) Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival. Sci Rep 11(1):12541","journal-title":"Sci Rep"},{"issue":"9","key":"2012_CR37","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/nm.2938","volume":"18","author":"A Ostman","year":"2012","unstructured":"Ostman A (2012) The tumor microenvironment controls drug sensitivity. Nat Med 18(9):1332\u20131334","journal-title":"Nat Med"},{"issue":"2","key":"2012_CR38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cps.2016.12.002","volume":"44","author":"NG Patel","year":"2017","unstructured":"Patel NG, Ramakrishnan V (2017) Microsurgical tissue transfer in breast reconstruction. Clin Plast Surg 44(2):345\u2013359","journal-title":"Clin Plast Surg"},{"issue":"4","key":"2012_CR39","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1194\/jlr.S091793","volume":"60","author":"KJ Prentice","year":"2019","unstructured":"Prentice KJ, Saksi J, Hotamisligil GS (2019) Adipokine FABP4 integrates energy stores and counterregulatory metabolic responses. J Lipid Res 60(4):734\u2013740","journal-title":"J Lipid Res"},{"key":"2012_CR40","volume-title":"Global cancer facts & figures 3rd edition","author":"Society AC","year":"2015","unstructured":"Society AC (2015) Global cancer facts & figures 3rd edition. American Cancer Society, Atlanta"},{"issue":"21","key":"2012_CR41","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1200\/JCO.2015.60.9271","volume":"33","author":"JA Sparano","year":"2015","unstructured":"Sparano JA, Zhao F, Martino S, Ligibel JA, Perez EA, Saphner T et al (2015) Long-term follow-up of the E1199 phase III trial evaluating the role of taxane and schedule in operable breast cancer. J Clin Oncol 33(21):2353\u20132360","journal-title":"J Clin Oncol"},{"key":"2012_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev.nutr.27.061406.093710","volume":"28","author":"J Storch","year":"2008","unstructured":"Storch J, Corsico B (2008) The emerging functions and mechanisms of mammalian fatty acid-binding proteins. Annu Rev Nutr 28:73\u201395","journal-title":"Annu Rev Nutr"},{"issue":"2","key":"2012_CR43","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/PRS.0000000000004072","volume":"141","author":"SMH Tuinder","year":"2018","unstructured":"Tuinder SMH, Beugels J, Lataster A, de Haan MW, Piatkowski A, Saint-Cyr M et al (2018) The lateral thigh perforator flap for autologous breast reconstruction: a prospective analysis of 138 flaps. Plast Reconstr Surg 141(2):257\u2013268","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"2012_CR44","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1038\/s41467-021-21671-w","volume":"12","author":"CG Urz\u00faa-Traslavi\u00f1a","year":"2021","unstructured":"Urz\u00faa-Traslavi\u00f1a CG, Leeuwenburgh VC, Bhattacharya A, Loipfinger S, van Vugt MATM, de Vries EGE et al (2021) Improving gene function predictions using independent transcriptional components. Nat Commun 12(1):1464","journal-title":"Nat Commun"},{"issue":"1","key":"2012_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0959-8049(98)00301-3","volume":"35","author":"G van Tienhoven","year":"1999","unstructured":"van Tienhoven G, Voogd AC, Peterse JL, Nielsen M, Andersen KW, Mignolet F et al (1999) Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer. 35(1):32\u20138","journal-title":"Eur J Cancer."},{"key":"2012_CR46","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.2174\/092986712804143349","volume":"19","author":"N Vazzana","year":"2012","unstructured":"Vazzana N, Riondino S, Toto V, Guadagni F, Roselli M, Davi G et al (2012) Obesity-driven inflammation and colorectal cancer. Curr Med Chem 19:5837\u20135853","journal-title":"Curr Med Chem"},{"key":"2012_CR47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s42255-019-0152-6","volume":"2","author":"J Vijay","year":"2020","unstructured":"Vijay J, Gauthier MF, Biswell RL, Louiselle DA, Johnston JJ, Cheung WA et al (2020) Single-cell analysis of human adipose tissue identifies depot and disease specific cell types. Nat Metab 2:97\u2013109","journal-title":"Nat Metab"},{"key":"2012_CR48","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/liv.14755","volume":"41","author":"L von Hessen","year":"2021","unstructured":"von Hessen L, Roumet M, Maurer MH, Lange N, Reeves H, Dufour JF et al (2021) High subcutaneous adipose tissue density correlates negatively with survival in patients with hepatocellular carcinoma. Liver Int 41:828\u2013836","journal-title":"Liver Int"},{"issue":"17","key":"2012_CR49","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1016\/j.ejca.2005.04.040","volume":"41","author":"AC Voogd","year":"2005","unstructured":"Voogd AC, van Oost FJ, Rutgers EJ, Elkhuizen PH, van Geel AN, Scheijmans LJ et al (2005) Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer 41(17):2637\u20132644","journal-title":"Eur J Cancer"},{"issue":"31","key":"2012_CR50","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH et al (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol 31(31):3997\u20134013","journal-title":"J Clin Oncol"},{"issue":"2","key":"2012_CR51","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1748-1716.2012.02409.x","volume":"205","author":"A Wronska","year":"2012","unstructured":"Wronska A, Kmiec Z (2012) Structural and biochemical characteristics of various white adipose tissue depots. Acta Physiol (Oxf) 205(2):194\u2013208","journal-title":"Acta Physiol (Oxf)"},{"issue":"4","key":"2012_CR52","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.amjsurg.2006.06.030","volume":"192","author":"H Zaha","year":"2006","unstructured":"Zaha H, Inamine S, Naito T, Nomura H (2006) Laparoscopically harvested omental flap for immediate breast reconstruction. Am J Surg 192(4):556\u2013558","journal-title":"Am J Surg"},{"issue":"5","key":"2012_CR53","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.molmed.2020.03.004","volume":"26","author":"J Zeng","year":"2020","unstructured":"Zeng J, Sauter ER, Li B (2020) FABP4: a new player in obesity-associated breast cancer. Trends Mol Med 26(5):437\u2013440","journal-title":"Trends Mol Med"},{"issue":"3","key":"2012_CR54","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/PRS.0000000000005316","volume":"143","author":"R Zhao","year":"2019","unstructured":"Zhao R, Kaakati R, Liu X, Xu L, Lee AK, Bachelder R et al (2019) CRISPR\/Cas9-mediated BRCA1 knockdown adipose stem cells promote breast cancer progression. Plast Reconstr Surg 143(3):747\u2013756","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"2012_CR55","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13046-020-01666-z","volume":"39","author":"C Zhao","year":"2020","unstructured":"Zhao C, Wu M, Zeng N, Xiong M, Hu W, Lv W et al (2020) Cancer-associated adipocytes: emerging supporters in breast cancer. J Exp Clin Cancer Res 39(1):156","journal-title":"J Exp Clin Cancer Res"},{"key":"2012_CR56","first-page":"SP14","volume":"20","author":"MP Zimmerman","year":"2014","unstructured":"Zimmerman MP, Pharm BS, Stanton RM (2014) Recurrence of breast cancer years after the initial tumor. Evid-Based Oncol 20:SP14","journal-title":"Evid-Based Oncol"}],"container-title":["Functional &amp; Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-02012-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-02012-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-02012-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:02:13Z","timestamp":1788962533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-026-02012-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2012"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-02012-w","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"256"}}